Skip to main content
SpringerLink
Log in

Progress in Anti-Cancer Chemotherapy

  • Conference proceedings
  • © 1999

Overview

Editors:
  1. Gabriel N. Hortobagyi

    1. MD Anderson Cencer Center, Cepartment of Breast Medical Oncology, University of Texas, Houston, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. David Khayat

    1. Pitié-Salpétrière Hospital, SOMPS, Paris Cedex 13, France

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • This volume describes selected examples of both diagnostic and therapeutic progress in areas of hematological malignancies and common human solid tumors, with emphasis in research that has immediate or very short-term clinical application

Part of the book series: Progress in Anti-Cancer Chemotherapy (ANTI-CANCER, volume 3)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (17 papers)

  1. Front Matter

    Pages i-3
    Download chapter PDF

  3. Ethic and Fundamental Research in Cancer

    1. Front Matter

      Pages 55-55
      Download chapter PDF

    2. Hereditary Breast Cancer: an Overview

      • C. J. D. Isaacs, B. N. Peshkin
      Pages 57-80

    3. Clinical Applications of Angiogenesis Inhibitors

      • I. J. Fidler, D. R. Bielenberg
      Pages 81-96

  4. Lung Cancer

    1. Front Matter

      Pages 57-57
      Download chapter PDF

    2. Current Management and New Leads in Small Cell Lung Cancer

      • F. A. Greco, J. D. Hainsworth
      Pages 99-108

    3. Progress in Lung Cancer Surgery

      • G. Motta
      Pages 109-130

    4. New Drug Combinations in NSCLC: Progress in Cancer Therapy

      • A. F. Soriano, P. A. Bunn Jr.
      Pages 131-174

  5. Urological Tumors

    1. Front Matter

      Pages 175-175
      Download chapter PDF

    2. Update in testicular cancer

      • L. H. Einhorn
      Pages 177-188

    3. Screening for Prostate Cancer: the good, the bad and the ugly

      • L. Denis
      Pages 189-197

  6. Melanoma

    1. Front Matter

      Pages 199-199
      Download chapter PDF

    2. The Development of Cancer Vaccines for the Treatment of Metastatic Melanoma

      • F. M. Marincola, S. A. Ronseberg
      Pages 201-218

    3. The Role of Interferon in the Adjuvant Treatment of Cutaneous Melanoma

      • N. Cascinelli, F. Belli
      Pages 219-230

  7. Infectious Agents and Cancers

    1. Front Matter

      Pages 231-231
      Download chapter PDF

    2. Molecular Mechanisms of Hepatitis B and C Viruses Related Liver Carcinogenesis

      • C. Brechot
      Pages 233-245
Back to top

Keywords

About this book

This is the third volume of our series Progress in Anti-Cancer Chemo­ therapy. Following the strategy of the first two volumes, it covers selected aspects of progress in this fast moving field of Oncology, with contribu­ tions from some of the world's best known leaders in both basic and clin­ ical research. This year we focused on seven areas: Three prominent Clinical investigators reviewed conceptual advances in cancer research. Dr Buzdar presented a history and overview of the protection of human subjects who participate in clinical research, and the mechanisms developed to assure the ethical conduct of research on human beings. Frei reviewed an exciting and rapidly moving area of che­ motherapy of solid tumors, including a cogent discussion of the issues related to dose-intensification. Fisher summarized conceptual advances in our therapeutic approach to breast cancer and the paradigm shifts that lead us to our current management strategies. From this summary he pro­ jected breast cancer research into the future, a daunting task under any circumstance. Fundamental research in cancer biology has been responsible for our improved understanding of the development and progession of malignant disease. Such understanding will lead to improved diagnosis, therapy, and eventually, prevention. Isaacs reviews the area of hereditary breast cancer, a topic undergoing rapid transformation and with mUltiple impli­ cations in the daily practice of medicine. Fidler, an international expert in metastasis research reviews the potential utility of angiogenesis inhib­ itors in research and the therapeutic ramifications.

Editors and Affiliations

  • MD Anderson Cencer Center, Cepartment of Breast Medical Oncology, University of Texas, Houston, USA

    Gabriel N. Hortobagyi

  • Pitié-Salpétrière Hospital, SOMPS, Paris Cedex 13, France

    David Khayat

Bibliographic Information

  • Book Title: Progress in Anti-Cancer Chemotherapy

  • Editors: Gabriel N. Hortobagyi, David Khayat

  • Series Title: Progress in Anti-Cancer Chemotherapy

  • DOI: https://doi.org/10.1007/978-2-8178-0918-2

  • Publisher: Springer Paris

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag France 1999

  • Softcover ISBN: 978-2-287-59666-7Published: 01 February 1999

  • eBook ISBN: 978-2-8178-0918-2Published: 17 April 2013

  • Edition Number: 1

  • Number of Pages: X, 307

  • Number of Illustrations: 14 b/w illustrations

  • Additional Information: Volume 1 and 2 published by Blackwell

  • Topics: Oncology

Publish with us

Policies and ethics

Back to top

Search

Navigation